8 research outputs found
Dexamethasone therapy in COVID-19 patients:implications and guidance for the management of blood glucose in people with and without diabetes
Get PDFThe RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial found that dexamethasone 6 mg once per day for 10 days reduced deaths by one-third in ventilated patients and by one-fifth in other patients, receiving oxygen therapy. This equates to the prevention of one death in around eight ventilated patients, or one in around 25 patients requiring oxygen
Maintaining glycaemic control during high-dose prednisolone administration for hyperemesis gravidarum in Type 1 diabetes
No full textInsulin glargine in combination with nateglinide in people with Type 2 diabetes: A randomized placebo-controlled trial
Get PDFPredicting the development of macrovascular disease in people with type 1 diabetes: A 9-year follow-up study
No full textEvaluation of antitumor activity of Urena lobata against Ehrlich ascites carcinoma treated mice
No full textMid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control
No full text
